Pfizer Stocks Rise as it Lifts COVID Vaccine Sales Outlook
In after-hours trading, stocks of Pfizer jumped as it boosted its full-year sales forecast for its Covid-19 vaccine after posting better than expected third-quarter results. Accordingly, the pharmaceutical firm climbed 0.75% or 0.34 points to $45.79 per share. Subsequently, it followed its Tuesday hike of 4.15% or 1.81 points to $45.45 per share. Moreover, Pfizer …
Pfizer Stocks Rise as it Lifts COVID Vaccine Sales Outlook Read More »